In the BioHarmony Drug Report Database

"Preview" Icon

Granisetron

Sancuso, Sustol (granisetron) is a small molecule pharmaceutical. Granisetron was first approved as Sancuso on 2008-09-12. It has been approved in Europe to treat neoplasms and vomiting. Granisetron hydrochloride’s patents are valid until 2025-01-22 (FDA).

 

Trade Name

 

Sancuso
 

Common Name

 

granisetron
 

ChEMBL ID

 

CHEMBL289469
 

Indication

 

neoplasms, vomiting
 

Drug Class

 

Serotonin 5-HT3 antagonists

Image (chem structure or protein)

Granisetron structure rendering